✦ LIBER ✦

Gemcitabine Combined with Oxaliplatin (GEMOX) as Second-Line Chemotherapy in Patients with Advanced Ovarian Cancer Refractory or Resistant to Platinum and Taxane

✍ Scribed by Raspagliesi, Francesco; Zanaboni, Flavia; Vecchione, Francesca; Hanozet, Francesco; Scollo, Paolo; Ditto, Antonino; Grijuela, Barbara; Fontanelli, Rosanna; Solima, Eugenio; Spatti, Gianbattista; Scibilia, Giuseppe; Kusamura, Shigeki

Book ID: 118032075
Publisher: S. Karger AG
Year: 2004
Tongue: English
Weight: 101 KB
Volume: 67
Category: Article
ISSN: 0030-2414
DOI: 10.1159/000082921

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of sabarubicin (MEN-107

A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer

✍ Francesco Caponigro; Pax Willemse; Roberto Sorio; Anne Floquet; Simon van Belle; 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 81 KB

High-dose 5-fluorouracil and leucovorin

High-dose 5-fluorouracil and leucovorin as second-line chemotherapy in patients with platinum-resistant epithelial ovarian cancer

✍ J. T. Kamphuis; M. C. Huider; G. J. Ras; C. A. H. Verhagen; I. Kateman; J. H. A. 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 265 KB

Second-Line Treatment with Intravenous G

Second-Line Treatment with Intravenous Gemcitabine and Oral Etoposide in Platinum-Resistant Advanced Ovarian Cancer Patients: Results of a Phase II Study

✍ Bruzzone, M.; Centurioni, M.G.; Giglione, P.; Gualco, M.; Merlo, D.F.; Miglietta 📂 Article 📅 2011 🏛 S. Karger AG 🌐 English ⚖ 469 KB

Cisplatin and vinorelbine as second-line

Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine

✍ De Pas, Tommaso; de Braud, Filippo; Mandalà, Mario; Curigliano, Giuseppe; Catani 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 55 KB

P-541 Second line chemotherapy with pacl

P-541 Second line chemotherapy with paclitaxel in advanced non-small cell lung cancer, relapsing or refractory to a combination chemotherapy containing cis-platinum (P)

✍ Buccheri, Gianfranco; Ferrigno, Domenico; Giordano, Maria C. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Phase II Study of Intravenous DX-8951f i

Phase II Study of Intravenous DX-8951f in Patients with Advanced Ovarian, Tubal, or Peritoneal Cancer Refractory to Platinum, Taxane, and Topotecan

✍ C. F. VERSCHRAEGEN; C. LEVENBACK; M. VINCENT; J. WOLF; M. BEVERS; E. LOYER; A. P 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB